Project Grant R35GM163790
- Federal Grant Award Summary The University of Michigan's Regents received a $429,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 5, 2026, with a completion date of December 31, 2030. This research initiative investigates the mechanisms by which mammalian cells sense, acquire, and maintain appropriate intracellular inorganic phosphate (Pi) levels in response to fluctuating...
- Federal Project Grant Award Summary The University of Michigan received a $995,204 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through March 31, 2029. This three-year technology development initiative focuses on engineering liposomal DNA-driven membrane fusion as a versatile delivery platform for proteins, nucleic acids, and lipid molecules into living...
- Federal Project Grant Award Summary The University of Michigan's Regents received a $426,539 Project Grant awarded on May 1, 2026, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to support research on context-specific cellular networks in bacterial pathogens. The research will be conducted at the Ann Arbor, MI campus through February 28, 2031. The project advances fundamental understanding of bacterial...
- Federal Grant Award Summary The University of Michigan has received a $424,264 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025 through May 31, 2030. This award supports the development of advanced quantitative analysis methodologies for long-read RNA-sequencing (RNA-seq) data at both bulk and single-cell dimensions. The research will advance understanding of gene...
- Federal Grant Award Summary The University of Michigan received a $862,279 Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074), effective June 1, 2026 through May 31, 2029. This award funds fundamental research investigating RNA-RNA interactions that regulate virulence gene expression in Listeria monocytogenes, a foodborne bacterial pathogen of significant public health concern. The research...
- Grant Award Summary The University of Michigan received a Project Grant of $420,066 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. This research initiative focuses on exploiting microbial regulatory networks to accelerate natural products discovery for pharmaceutical applications. The project will systematically characterize how regulatory networks...
- Federal Project Grant Award Summary The University of Michigan received a $2.01 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, with completion targeted for August 31, 2029. This four-year research initiative focuses on enzyme-inspired multimetallic cooperativity and the design of synthetic model systems that investigate how metal ion identity and pairing...
- Federal Grant Award Summary Michigan State University received a $417,243 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 10, 2025, with a completion date of July 31, 2030. The project develops novel chemical, chemoenzymatic, and chemoselective ligation strategies to synthesize homogeneous proteoglycan-like glycopeptides and glycoproteins bearing defined glycan structures....
- Federal Project Grant Award Summary The University of Michigan has received a $400,881 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 26, 2026, with completion targeted for December 31, 2030. This award funds research to uncover the principles of tissue morphogenesis through a modularity framework, focusing on early brain and epidermal development in the Drosophila embryo....
- Federal Grant Award Summary The University of Michigan received a $2.99 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 1, 2025, through August 31, 2029. This award supports biomedical research investigating reactive oxygen species (ROS) as early-life modulators of lifespan and age-related disease development. The research employs a multipronged approach utilizing model organisms—including Caenorhabditis elegans...
The University of Michigan received a $425,916 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026 through March 31, 2031. This five-year research initiative investigates the mechanisms by which cells maintain, repair, and remove damaged lysosomes—critical cellular organelles responsible for catabolism and metabolic regulation. The research employs cell-biological, biochemical, and biophysical approaches to examine how Endosomal Sorting Complex Required for Transport (ESCRT) machinery coordinates membrane remodeling, lipid delivery, and cholesterol management to preserve lysosomal integrity under stress conditions. The project deliverables include fundamental scientific discoveries regarding how individual ESCRT machinery components contribute to lysosomal resilience and repair, coupled with an integrated understanding of cellular recognition mechanisms for removing irreparably damaged lysosomes. Research will be conducted at the University of Michigan's Ann Arbor campus and will integrate findings from discrete stress response studies into a comprehensive framework of lysosomal membrane homeostasis. The outputs are expected to advance understanding of cellular defensive mechanisms and establish foundational knowledge applicable to disease diagnosis, treatment, and prevention across multiple biological and medical disciplines.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $425.9k | 5/14/26 |